Christine M. Lovly is a physician scientist whose clinical practice focuses on treatment of patients with lung cancer. Her research program focuses on two major themes: stratification of lung tumors into clinically relevant molecular subsets and determination of the molecular mechanisms leading to therapeutic resistance. Dr. Lovly is an elected member of the American Society for Clinical Investigation. She serves on the Scientific Leadership Boards for the GO2 Foundation for Lung Cancer Research, the LUNGevity Foundation, and the Lung Cancer Research Foundation. Dr. Lovly is a member of the AACR Science Policy and Government Affairs committee and co-chair of the Tobacco Products and Cancer subcommittee. She serves on the NCCN guidelines panel for Non-Small Cell Lung Cancer and is co-chair of the ECOG-ACRIN Lung Biology Committee. In 2021, Dr. Lovly was awarded the ECOG-ACRIN Young Investigator Award. In 2022, she received the GO2 Foundation Asclepios Award honoring research pioneers in the fight to end lung cancer.